Falling sequencing costs, precision medicine and broader clinical use are driving WGS adoption, creating opportunities in long-read platforms, automation, cloud bioinformatics and data services.Dublin ...
Precision medicine, drug discovery and cell/gene therapies are driving adoption, creating opportunities in automation, spatial multi-omics, AI bioinformatics and clinical diagnostics.Dublin, Sept. 24, ...
Falling costs and deeper genetic insights are accelerating adoption, creating opportunities in predictive diagnostics, pharmacogenomics and direct-to-consumer testing.Dublin, Sept. 24, 2026 (GLOBE ...